Development of New MDR-Tuberculosis Drugs. (Record no. 60548)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03370nam a22004693i 4500 |
| 001 - CONTROL NUMBER | |
| control field | EBC3019875 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | MiAaPQ |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240729124128.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d | |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cnu|||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 240724s2010 xx o ||||0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781616684785 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9781616682330 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (MiAaPQ)EBC3019875 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (Au-PeEL)EBL3019875 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (CaPaEBR)ebr10674883 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)923662021 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | MiAaPQ |
| Language of cataloging | eng |
| Description conventions | rda |
| -- | pn |
| Transcribing agency | MiAaPQ |
| Modifying agency | MiAaPQ |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RM409 -- .V56 2010eb |
| 082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615.5/8 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Vinšová, Jarmila. |
| 245 10 - TITLE STATEMENT | |
| Title | Development of New MDR-Tuberculosis Drugs. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 1st ed. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Hauppauge : |
| Name of producer, publisher, distributor, manufacturer | Nova Science Publishers, Incorporated, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2010. |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | ©2010. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (112 pages) |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 490 1# - SERIES STATEMENT | |
| Series statement | Pharmacology - Research, Safety Testing and Regulation |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Intro -- DEVELOPMENT OF NEW MDR-TUBERCULOSIS DRUGS -- DEVELOPMENT OF NEW MDR-TUBERCULOSIS DRUGS -- CONTENTS -- PREFACE -- INTRODUCTION -- Chapter 1 RESISTANCE TO COMMONLY USED DRUGS, MECHANISM OF THE ACTION -- ISONIAZID, ETHIONAMIDE -- RIFAMPICIN -- PYRAZINAMIDE -- ETHAMBUTOL -- STREPTOMYCIN -- FLUOROQUINOLONES -- Chapter 2 RESEARCH OF NOVEL MDR-POTENTIAL DRUGS -- 1. STRUCTURE MODIFICATION OF KNOWN COMPOUNDS (INH, ETH, RIF AND RIFAMYCIN DERIVATIVES, PZA, EMB, AND QUINOLONES) -- 2. NEW LEADS WITH NOVEL MECHANISM OF THE ACTION [74] (LINEZOLID, TMC207, PA-824, OPC-67683, BM212, SQ109, FAS20013, LL-3858) -- 3. NOVEL DRUG TARGETS [109] -- 3.1. Cell Wall Biosynthesis -- Cell Wall Structure of M. Tuberculosis [111] -- 3.1.1. Mycolic Acid Synthesis Inhibitors -- Fatty acid biosynthesis [118] -- DesA3 -- 3.1.2. Protein Synthesis Inhibitors [119] -- Inhibition of InhA -- 3.1.3. Polysaccharide Biosynthesis Inhibitors [137] -- Nitrofuranylamides -- 3.2. Targeting P450 Enzymes [148] -- 3.3. Targeting Isocitrate Lyases -- 3.4. FtsZ-Targeting Compounds -- 3.6. Other Targets -- Inhibition of bacterial kinases [164] -- Gyrase Blockers -- Inhibition of Efflux Pumps -- Shikimate Pathway -- Siderophore Biosynthesis -- Biotin Biosynthesis -- Other Potential Targets -- 4. INVESTIGATION OF "NON-ANTI-TUBERCULOUS" DRUGS AND THEIR DERIVATIVES -- 5. OTHER ACTIVE SYNTHETIC COMPOUNDS -- 6. OTHER ACTIVE, NATURALLY-OCCURRING COMPOUNDS -- Chapter 3 CONCLUSION -- ACKNOWLEDGMENTS -- REFERENCES -- INDEX. |
| 588 ## - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Description based on publisher supplied metadata and other sources. |
| 590 ## - LOCAL NOTE (RLIN) | |
| Local note | Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antitubercular agents. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Multidrug-resistant tuberculosis -- Chemotherapy. |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Krátký, Martin. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| Main entry heading | Vinšová, Jarmila |
| Title | Development of New MDR-Tuberculosis Drugs |
| Place, publisher, and date of publication | Hauppauge : Nova Science Publishers, Incorporated,c2010 |
| International Standard Book Number | 9781616682330 |
| 797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN) | |
| Corporate name or jurisdiction name as entry element | ProQuest (Firm) |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | Pharmacology - Research, Safety Testing and Regulation |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3019875">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3019875</a> |
| Public note | Click to View |
No items available.